1. Home
  2. GNFT vs BLDE Comparison

GNFT vs BLDE Comparison

Compare GNFT & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • BLDE
  • Stock Information
  • Founded
  • GNFT 1999
  • BLDE 2014
  • Country
  • GNFT France
  • BLDE United States
  • Employees
  • GNFT N/A
  • BLDE N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • BLDE Aerospace
  • Sector
  • GNFT Health Care
  • BLDE Consumer Discretionary
  • Exchange
  • GNFT Nasdaq
  • BLDE Nasdaq
  • Market Cap
  • GNFT 214.5M
  • BLDE 285.2M
  • IPO Year
  • GNFT 2019
  • BLDE N/A
  • Fundamental
  • Price
  • GNFT N/A
  • BLDE $4.18
  • Analyst Decision
  • GNFT Strong Buy
  • BLDE Strong Buy
  • Analyst Count
  • GNFT 1
  • BLDE 2
  • Target Price
  • GNFT $13.00
  • BLDE $6.25
  • AVG Volume (30 Days)
  • GNFT 4.2K
  • BLDE 855.3K
  • Earning Date
  • GNFT 04-24-2025
  • BLDE 08-06-2025
  • Dividend Yield
  • GNFT N/A
  • BLDE N/A
  • EPS Growth
  • GNFT N/A
  • BLDE N/A
  • EPS
  • GNFT 0.03
  • BLDE N/A
  • Revenue
  • GNFT $73,187,701.00
  • BLDE $251,485,000.00
  • Revenue This Year
  • GNFT $15.98
  • BLDE $5.58
  • Revenue Next Year
  • GNFT N/A
  • BLDE $8.56
  • P/E Ratio
  • GNFT $125.30
  • BLDE N/A
  • Revenue Growth
  • GNFT 105.01
  • BLDE 8.67
  • 52 Week Low
  • GNFT $2.55
  • BLDE $2.35
  • 52 Week High
  • GNFT $6.42
  • BLDE $5.17
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 47.81
  • BLDE 62.91
  • Support Level
  • GNFT $3.61
  • BLDE $3.94
  • Resistance Level
  • GNFT $3.95
  • BLDE $4.24
  • Average True Range (ATR)
  • GNFT 0.14
  • BLDE 0.20
  • MACD
  • GNFT -0.01
  • BLDE 0.00
  • Stochastic Oscillator
  • GNFT 57.01
  • BLDE 93.98

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Share on Social Networks: